The box a domain of high mobility group box-1 protein as an efficient siRNA carrier with anti-inflammatory effects

Journal of Cellular Biochemistry

Volumn 113, Issue 1, 2012, Pages 122-131

  Lee, Sanghyun ^a   Song, Hojung ^a   Kim, Hyun Ah ^a   Oh, Binna ^a   Lee, Dong Yun ^a   Lee, Minhyung ^a  

^a Hanyang University   (South Korea)

Author keywords

Anti inflammation; Gene therapy; High mobility group box 1; Recombinant peptide; siRNA delivery

Indexed keywords

FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN; HEPARIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN A; LIPOPOLYSACCHARIDE; LUCIFERASE; NICKEL COMPLEX; POLYETHYLENEIMINE; POLYMYXIN B; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHROMATOGRAPHY; CYTOTOXICITY; GENE THERAPY; HUMAN; HUMAN CELL; INFLAMMATION; ION EXCHANGE CHROMATOGRAPHY; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

ANIMALS; CELL LINE; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE THERAPY; HEK293 CELLS; HMGB PROTEINS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84055222636     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23334     Document Type: Article

References (47)

1. af Klint E, Grundtman C, Engstrom M, Catrina AI, Makrygiannakis D, Klareskog L, Andersson U, Ulfgren AK,. 2005. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels. Arthritis Rheum 52: 3880-3889. (Pubitemid 41798227)
2. Agnello D, Wang H, Yang H, Tracey KJ, Ghezzi P,. 2002. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 18: 231-236. (Pubitemid 34775431)
3. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ,. 2002. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 72: 1084-1091. (Pubitemid 36008878)
4. Balicki D, Reisfeld RA, Pertl U, Beutler E, Lode HN,. 2000. Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma. Proc Natl Acad Sci USA 97: 11500-11504.
5. Banerjee S, Kundu TK,. 2003. The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription. Nucleic Acids Res 31: 3236-3247. (Pubitemid 37441783)
6. Benns JM, Choi JS, Mahato RI, Park JS, Kim SW,. 2000. pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L- lysine) comb shaped polymer. Bioconjug Chem 11: 637-645.
7. Gong Q, Xu JF, Yin H, Liu SF, Duan LH, Bian ZL,. 2009. Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice. Scand J Immunol 69: 29-35.
8. Grasser KD,. 2003. Chromatin-associated HMGA and HMGB proteins: Versatile co-regulators of DNA-dependent processes. Plant Mol Biol 53: 281-295. (Pubitemid 38097961)
9. Han JS, Kim K, Lee M,. 2009. A high mobility group B-1 box A peptide combined with an artery wall binding peptide targets delivery of nucleic acids to smooth muscle cells. J Cell Biochem 107: 163-170.
10. Han S, Mahato RI, Sung YK, Kim SW,. 2000. Development of biomaterials for gene therapy. Mol Ther 2: 302-317.
11. Ikeda Y, Taira K,. 2006. Ligand-targeted delivery of therapeutic siRNA. Pharm Res 23: 1631-1640. (Pubitemid 44200525)
12. Kaneda Y, Iwai K, Uchida T,. 1989. Introduction and expression of the human insulin gene in adult rat liver. J Biol Chem 264: 12126-12129. (Pubitemid 19191091)
13. Kang HC, Lee M, Bae YH,. 2005. Polymeric gene carriers. Crit Rev Eukaryot Gene Expr 15: 317-342.
14. Kaouass M, Beaulieu R, Balicki D,. 2006. Histonefection: Novel and potent non-viral gene delivery. J Control Release 113: 245-254. (Pubitemid 43983040)
15. Kawahara K, Hashiguchi T, Masuda K, Saniabadi AR, Kikuchi K, Tancharoen S, Ito T, Miura N, Morimoto Y, Biswas KK, Nawa Y, Meng X, Oyama Y, Takenouchi K, Shrestha B, Sameshima H, Shimizu T, Adachi T, Adachi M, Maruyama I,. 2009. Mechanism of HMGB1 release inhibition from RAW264.7cells by oleanolic acid in Prunus mume Sieb. et Zucc. Int J Mol Med 23: 615-620.
16. Kim K, Han JS, Kim HA, Lee M,. 2008a. Expression, purification and characterization of TAT-high mobility group box-1A peptide as a carrier of nucleic acids. Biotechnol Lett 30: 1331-1337.
17. Kim K, Han JS, Park JH, Ko KS, Lee M,. 2008b. Expression and characterization of a recombinant high mobility group box 1 AB peptide with a 6-histidine tag for delivery of necleic acids. Enzyme Microbial Technol 43: 410-416.
18. Kim K, Han JS, Park JH, Ko KS, Lee M,. 2008c. Expression and characterization of a recombinant high mobility group box 1 AB peptide with a 6-histidine tag for delivery of nucleic acids. Enzyme Microbial Technol 43: 410-416.
19. Kim WJ, Christensen LV, Jo S, Yockman JW, Jeong JH, Kim YH, Kim SW,. 2006b. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 14: 343-350. (Pubitemid 44184964)
20. Kokkola R, Li J, Sundberg E, Aveberger AC, Palmblad K, Yang H, Tracey KJ, Andersson U, Harris HE,. 2003. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 48: 2052-2058. (Pubitemid 36828701)
21. Lee M, Kim SW,. 2002. Polymeric gene carriers. Pharm News 9: 407-415. (Pubitemid 37107970)
22. Lee M, Kim SW,. 2005. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res 22: 1-10. (Pubitemid 40558140)
23. Lee M, Nah JW, Kwon Y, Koh JJ, Ko KS, Kim SW,. 2001. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm Res 18: 427-431. (Pubitemid 32592572)
24. Lee M, Rentz J, Han SO, Bull DA, Kim SW,. 2003. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Ther 10: 585-593. (Pubitemid 36432610)
25. Liu H, Yao YM, Ding LH, Zhang H, Yuan B, Song Q, Ye QN, Huang CF, Sheng ZY,. 2009. High mobility group box-1 protein acts as a coactivator of nuclear factor of activated T cells-2 in promoting interleukin-2 transcription. Int J Biochem Cell Biol 41: 641-648.
26. Logsdon CD, Fuentes MK, Huang EH, Arumugam T,. 2007. RAGE and RAGE ligands in cancer. Curr Mol Med 7: 777-789.
27. Lv B, Wang H, Tang Y, Fan Z, Xiao X, Chen F,. 2009. High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thromb Haemost 102: 352-359.
28. Malek A, Merkel O, Fink L, Czubayko F, Kissel T, Aigner A,. 2009. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes. Toxicol Appl Pharmacol 236: 97-108.
29. Mantell LL, Parrish WR, Ulloa L,. 2006. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders. Shock 25: 4-11.
30. Nishikawa M, Huang L,. 2001. Nonviral vectors in the new millennium: Delivery barriers in gene transfer. Hum Gene Ther 12: 861-870. (Pubitemid 32681851)
31. Puebla I, Esseghir S, Mortlock A, Brown A, Crisanti A, Low W,. 2003. A recombinant H1 histone-based system for efficient delivery of nucleic acids. J Biotechnol 105: 215-226. (Pubitemid 37315764)
32. Pullerits R, Jonsson IM, Verdrengh M, Bokarewa M, Andersson U, Erlandsson-Harris H, Tarkowski A,. 2003. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum 48: 1693-1700. (Pubitemid 36682378)
33. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S, Moskowitz MA,. 2008. Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 28: 927-938. (Pubitemid 351589627)
34. Quivy V, Van Lint C,. 2004. Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem Pharmacol 68: 1221-1229. (Pubitemid 39094288)
35. Sasahira T, Kirita T, Bhawal UK, Ikeda M, Nagasawa A, Yamamoto K, Kuniyasu H,. 2007. The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma. Virchows Arch 450: 287-295. (Pubitemid 46376559)
36. Scaffidi P, Misteli T, Bianchi ME,. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195. (Pubitemid 34773774)
37. Sioud M,. 2005. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 348: 1079-1090. (Pubitemid 40602367)
38. Stott K, Tang GS, Lee KB, Thomas JO,. 2006. Structure of a complex of tandem HMG boxes and DNA. J Mol Biol 360: 90-104. (Pubitemid 43927811)
39. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, Maruyama I,. 2003. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48: 971-981. (Pubitemid 36418239)
40. Thomas JO,. 2001. HMG1 and 2: Architectural DNA-binding proteins. Biochem Soc Trans 29: 395-401.
41. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ,. 2002. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99: 12351-12356.
42. van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, Nawroth PP, Bierhaus A, Tracey KJ, van der Poll T,. 2009. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products (Rage) in hmgb1 induced inflammation in vivo. Shock 31: 280-284.
43. van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, Nawroth PP, Bierhaus A, Tracey KJ, Poll T,. 2009. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 31: 280-284.
44. Wagstaff KM, Glover DJ, Tremethick DJ, Jans DA,. 2007. Histone-mediated transduction as an efficient means for gene delivery. Mol Ther 15: 721-731. (Pubitemid 46431992)
45. Wang H, Zhu S, Zhou R, Li W, Sama AE,. 2008. Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med 10: e32.
46. Yao X, Zhao G, Yang H, Hong X, Bie L, Liu G,. 2009. Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma. J Cancer Res Clin Oncol 136: 677-684.
47. Zhang CL, Shu MG, Qi HW, Li LW,. 2008. Inhibition of tumor angiogenesis by HMGB1 A box peptide. Med Hypotheses 70: 343-345.